Theralase Technologies Pioneers Light-Activated Cancer Therapies

Highlights,Successful Fundraising,: Theralase Technologies has raised $544,000 through a non-brokered private placement, which will support its clinic...

Shield Therapeutics Shares Rise 8% Following Phase III Trial Success

Highlights,Positive Phase III Trial Results: Shield Therapeutics announced successful phase III trial results for its iron deficiency treatment, Accru...

Lifeward Ltd. (Nasdaq: LFWD) Expands Offerings in Germany with Alter...

Lifeward Ltd. (Nasdaq:LFWD), a leading innovator in rehabilitation and recovery solutions, has announced an exciting expansion of its product offering...

Regeneron Faces Setback After Court Ruling on Eylea Biosimilar

Headlines,Regeneron Pharmaceuticals' shares fell by 4.63% following a court ruling.,The decision involved a legal dispute with Amgen regarding the bio...

Takeda Secures Approval for FRUZAQLA® in Japan, Offering New Hope fo...

HUTCHMED (China) Limited (“HUTCHMED”) has announced a significant milestone in cancer treatment with its partner Takeda Pharmaceutical Company Limited...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) Welcomes New CEO Catherin...

Acadia Pharmaceuticals Inc. has announced a significant leadership change with Catherine Owen Adams stepping in as the new Chief Executive Officer (CE...

DBV Technologies (Nasdaq: DBVT) Completes Patient Screening for VITE...

DBV Technologies (Nasdaq:DBVT), a clinical-stage biopharmaceutical company, has announced a major advancement in its research efforts against peanut a...

Scancell Holdings Unveils Strategic Roadmap for Next 18 Months

Scancell Holdings PLC, a company specializing in,Healthcare Sector,, has announced its strategic roadmap for the upcoming 18 months, building on subst...

VSee Health Reports Growth Post-Merger and Expansion of Telehealth S...

Overview of VSee Health, Inc. (NASDAQ: VSEE),VSee Health, Inc. (NASDAQ: VSEE), a prominent telehealth service provider, has recently disclosed its bus...

Understanding the Recent Upgrade for Applied Therapeutics (APLT)

Headlines,Applied Therapeutics Inc.,(NASDAQ:APLT),has received a rating upgrade reflecting positive changes in earnings estimates.,The upgrade is base...

ANGLE Deal Paves the Way for 'Pan-Cancer' Diagnostic

A Major,Healthcare sector,player, ANGLE PLC has announced a significant partnership with NuProbe USA aimed at accelerating the development of a pionee...

AstraZeneca (AZN) Experiences Notable Market Shift: Key Insights

Headlines,AstraZeneca,(NASDAQ:AZN),closed at $78.38, down 0.66%, compared to a minor loss in the S&P 500.,Over the past month, shares have decreased b...

Vanda Pharmaceuticals decries FDA’s rejection of stomach paralysis d...

The company has criticized the FDA for failing to hold advisory committee meetings as well as going against the FDCA.

Gilead Sciences stock nears its all-time high: buy or sell?

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million settlement with American...

Stryker's Latest Acquisition and Its Impact on Stock Performance

Headlines,Stryker Corporation has finalized the acquisition of care.ai, a company known for its AI-driven virtual care solutions.,The acquisition aims...

Merit Medical's WRAPSODY Trial Yields Positive Results

Headlines,Merit Medical Systems reported positive 6-month outcomes from the WRAPSODY trial's arteriovenous (AV) fistula arm.,The trial data, presented...

Rockwell Medical Stock Soars 108.5% YTD: Is It a Top Performer?

Headlines,Rockwell Medical's stock has surged by over 108% year-to-date, significantly outpacing industry and benchmark growth.,The company has excell...

Teladoc Sees 12% Surge Amid Growing BetterHelp Web Traffic

Headlines,Teladoc Health's shares increased nearly 12%, driven by improved web traffic for its BetterHelp platform.,BetterHelp saw a 12% rise in web t...

How Novartis plans to thrive without competing directly with Eli Lil...

As weight-loss treatments dominate the pharmaceutical market, Swiss drugmaker Novartis AG (SWX: NOVN) is choosing a different path. While competitors...

Structure Therapeutics (NASDAQ:GPCR) Announces Key Leadership Appoin...

Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company specializing in novel oral small molecule therapeutics fo...